Here are Wednesday’s biggest calls on Wall Street:
Cantor said it is bullish on shares of CoreWeave.
“We believe CoreWeave should benefit from secular growth trends in AI, specifically large language model (LLM) training and inference based usage, as an enabling software-driven AI-focused hyperscaler, comfort in near-term demand/supply imbalance, and competitive differentiation.”
Read more.
Goldman Sachs downgraded the German banking giant mainly on valuation.
“However, given the recent rally in the share price, Deutsche Bank now trades at a P/E multiple which is roughly in line with our broader coverage — at 10x our 2025E EPS estimate, and 9x 2026E.”
Read more.
Wells Fargo said it is sticking with the stock heading into earnings on Wednesday after the bell.
“Our Overweight rating is based on our positive stance on NVIDIA’s competitive positioning in gaming GPUs and expanding growth opportunities in data center, HPC [high performance computing], and emerging / expanding AI opportunities.”
Piper Sandler said shares of the biotech company are well positioned.
“We are initiating on Inventiva SA (IVA) with an Overweight rating and $26 PT.”
Goldman Sachs said it is bullish ahead of Apple’s product event on Sept. 9.
“Though in the past AAPL’s September event has had nominal impacts on day-of stock price performance, we are encouraged by reports surrounding (1) form factor updates to iPhone 17 models (17 ‘Air’ model, larger base screen size); (2) the potential for a price increase to the iPhone 17 Pro…”
Loop called DoorDash a “category killer.”
“While valuation leads gig-economy peers and the stock is not cheap, we think that with superior growth, considerable earnings power beneath ongoing investment, open ended opportunity and best-in-class management, a premium is warranted. Reiterate Buy and $305 PT.”
KeyBanc said the natural resources company is well positioned.
“We initiate coverage of Mach Natural Resources LP with an OW rating and an $18 PT.”
JPMorgan said it sees “limited visibility” of a turnaround plan.
“We are downgrading Krispy Kreme shares to Underweight from Neutral and continue to not publish a price target.”
Bank of America said it is bullish on the biotech company’s treatment for liver disease.
“We are upgrading Vir to Buy from Neutral and raising our PO to $14 from $12 as we think the market is underestimating the potential for its asset for treatment of severe liver disease caused by hepatitis delta virus.”
JPMorgan upgraded the LatAm media company and said it is well positioned for growth.
“We upgrade Televisa to Overweight from Neutral, mostly on a more constructive view on its media asset (a 45% stake in TelevisaUnivision), as it has successfully started to generate cash and deleverage, while growing at a quicker pace than its key US peers…”
Jefferies said the stock is well positioned for a Taylor Swift-Travis Kelce engagement.
“Swift is no stranger to the brand, having been mentioned on RL earnings calls for wearing Ralph Lauren for over two years. Swift even wore Ralph Lauren for the cover photo for Time person of the year in 2023. We see this as an encouraging catalyst for the brand, especially ahead of Swift’s upcoming album release in early October and the start of football season for Kelce.”
HSBC said in its upgrade of Amer that it sees another “leg of growth” for the sporting goods company.
“After being on the sidelines for a while following our downgrade late last year, we are again becoming constructive on the name.”
Read more.
The firm said the “bear case has played out” for the stock.
“That said, Lilly’s move to increase the prices outside the US sends a clear signal that the company might remain price disciplined.”
CLSA said Micron is “riding the crest of the AI wave.”
“Micron is well-positioned to capitalise on the demand for high bandwidth memory (HBM) from AI customers and to benefit from the healthy demand-supply balance in DRAM in 2H25-2026.”
Wedbush said the autonomous company is “uniquely positioned to capitalize on the accelerating adoption of AI-driven last mile delivery vehicles.”
“We are initiating coverage on Serve Robotics with an OUTPERFORM rating and a $15 price target. In our view, Serve Robotics has established a pioneering autonomous delivery platform that is uniquely positioned to capitalize on the accelerating adoption of AI-driven last mile delivery vehicles.”
Mizuho said shares of the patient management software company have plenty more room to run.
“We initiate coverage of PHR with an Outperform rating and $36 PT. Phreesia is a leader in Patient Intake Management software for practitioners.”